Bionica Emas will create 35 jobs in Westmeath with the establishment of a storage, distribution and labeling site in Ireland.
he company provides a range of services to the pharmaceutical and biotechnology industry, including access to drugs and ancillaries for use in clinical trials.
The company is opening a 7,000 square foot facility in Kilbeggan due to growing demand for the services it provides to its customers in the European Union, United States and Asia-Pacific.
The facility will allow a major expansion of existing logistics and storage capacities. It will be used to store, distribute and label drugs for use around the world.
The project is supported by the Irish government through IDA Ireland.
It is expected that after completion of the facility, Bionical Emas will continue to expand its Ireland-based operations and workforce across its three service areas: clinical development, early access programs and clinical trial delivery, according to an IDA Ireland press release.
IDA Ireland Executive Director Mary Buckley said Bionical Emas will join the strong group of life sciences companies in Ireland.
“This is a great victory for the Midlands region and in particular for Kilbeggan and the company will be a major contributor to the local economy,” Ms. Buckley said.
Founded in 2009 and based in England, Bionica Emas has offices in the UK, US and Australia.
Irishman Philip Dunne, an experienced biopharmaceutical executive, will lead the operation here.
Mr. Dunne said: “Accessing the incredible talent of the region, in addition to excellent transport links, will allow us to continue to rely on the market-leading services for which Bionical Emas is well known around the world. “